• Applied directly to the wound where it begins to absorb the exudate that may impair tissue regeneration and work as a hemostatic agent to control minor bleeding
• Provides a physiologically favorable environment that encourages wound healing
DermaCol™ 100 Collagen Sheet is indicated for the management of moderately to heavily exuding wounds and to control minor bleeding.
DermaCol™ 100 Collagen Sheet may be used for the management of exuding wounds such as: pressure injuries, venous stasis ulcers, diabetic ulcers, acute wounds, eg, trauma and surgical wounds, and partial-thickness burns.
Do not use on patients with a known allergy or sensitivity to bovine collagen.
Wounds may appear to be larger during the first several days of treatment due to reduction of swelling. An increase in drainage may be seen in the first several days of treatment.
Some reactions such as transitory pain, bleeding, blistering, swelling, and redness have been reported in isolated cases using a similar product. If these conditions continue for more than 3 to 5 days, discontinue use of the product and notify your physician.
Store in a cool, dry storage environment. Keep away from sunlight.
|Antimicrobial format available|
|Compatible w/ topicals||●|
|Conforms readily to wound||●|
|Gels on contact w/ exudate||●|
|Limited shelf life|
|Secondary dressing required||●|
|Usable on infected wounds|
|Variety of sizes||●|
|Educational Material Available||●|
|Free Samples/Trials Available||●|
|Published Clinical Article Available|
Moderate/Highly Exudating Wounds
Use under the guidance of a health care professional. Prepare wound site and surrounding skin. Apply the collagen dressing to the entire wound surface. Cover with secondary dressing.
Dressing may be left in place for up to 7 days.
DermaRite is a producer of skin care, wound care, nutrition, and infection control products, devoted to improving the lives of patients and caregivers across all health care settings.